Drittmittel-geförderte Forschungsprojekte

• Nuclear receptors as therapeutic targets in cholestasis (FWF P 18613-B05; Projektleitung: M. Trauner)
• 24-nor-ursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis
  (FWF P 19118-B05; Projektleitung: M.Trauner)
• Role of hepatobiliary bile acid transporters and bile acid-activated nuclear receptors in the control of hepatic lipid metabolism and defense against lipotoxicity (FWF-Spezialforschungsbereich, Projektleitung: M. Trauner)
• Genome-Austria Tissue Bank (GATiB): Specification and documentation of metabolic and neoplastic diseases
  (BMBWK; Projektleitung: M. Trauner)
• Role of Klebsiella oxytoca in the pathogenesis of antibiotic-associated colitis and other types of diarrhea and colitis (Hygienefonds der Medizinischen Universität Graz; Projektleitung: Ch. Högenauer)